Table 1

Univariate analysis of some categorical variables in cases and controls

Categorical variablesCasesControlsp Value
TotalNo of positive (%)TotalNo of positive (%)
*Beta blockers, diuretics, calcium channel antagonists, cardiac glycosides, angiotensin converting enzyme inhibitors, angiotensin receptor blockers, alpha blockers, antiarrhythmic agents.
†Conversion: phacoemulsification conversion to ECCE.
‡Data not shown for retrobulbar LA and intracameral LA due to small numbers.
IHD, ischaemic heart disease; CVA, cerebral vascular accident; ECCE, extracapsular cataract extraction; LA, local anaesthesia; PC, posterior capsule; SCH, suprachoroidal haemorrhage; GA, general anaesthesia; IOP, intraocular pressure; BP, blood pressure.
Systemic
    Cardiovascular drugs*10865 (58.3)449128 (28.5)<0.001
    Hyperlipidaemia5610 (17.9)44828 (6.3)0.005
    Anaemia877 (8.8)44913 (2.9)0.013
    Peripheral vascular disease987 (7.1)4489 (2)0.014
    Diabetes1085 (4.6)44955 (12.2)0.02
    Female sex10880 (74)449279 (62)0.02
    Bleeding diatheses1013 (3.1)4472 (0.4)0.046
    Hypertension10652 (49.1)449186 (41.4)>0.1
    Heart Failure1014 (4.0)44925 (5.6)>0.1
    IHD10112 (11.9)44950 (11.1)>0.1
    CVA1007 (7.0)44935 (7.8)>0.1
    Respiratory disease10513 (12.4)44868 (15.2)>0.1
    Aspirin10421 (20.2)449109 (24.3)>0.1
    Warfarin1056 (5.7)44915 (3.3)>0.1
Ophthalmic
    Glaucoma10835 (32.4)44929 (6.5)<0.001
    Past ocular surgery1076 (5.6)4486 (1.3)0.015
Operative
Procedure109449
    Phacoemulsification83 (76.2)415 (92.4)>0.1
    ECCE12 (11.0)26 (5.8)0.038
    Conversion†14 (12.8)8 (1.8)<0.001
    LA types‡105399
        Peribulbar47 (44.8)284 (71.2)<0.001
        Sub-Tenon’s45 (42.9)83 (20.8)<0.001
        Topical11 (10.5)13 (3.3)<0.001
    Orbital compression9349 (52.7)389306 (78.7)<0.001
    PC rupture before SCH10822 (20.4)43520 (4.6)<0.001
    GA1083 (2.8)44747 (10.5)0.012
    Consultant surgeon10876 (70.4)448257 (57.4)0.013
    Right eye10852 (48.1)449254 (56.6)>0.1
    Scleral section10810 (9.3)44836 (8.0)>0.1